Although systemic lupus erythematosus (SLE) is usually evaluated with regard to autoimmune reactivity toward the kidney, there are multiple psychiatric abnormalities associated with this autoimmune disease. Lupus-prone male NZM88 mice, derived from NZB/NZW F1 mice, develop early neuropsychiatric manifestations without any signs of nephritis. In addition to the usual repertoire of antibody specificities, including autoantibodies to dsDNA and renal antigens, mice of this inbred strain express autoantibodies to numerous brain antigens. Here, we show that autoantibodies to brain antigens, assessed by Western analysis, are as individually varied as are the diverse neuropsychiatric manifestations observed in SLE patients. Additionally, a monoclonal antibody derived from the spleen of an untreated NZM88 male when injected into healthy BALB/cByJ, but not C57BL/6J, mice induced behaviors similar to those of lupus-prone NZM88 mice. This monoclonal antibody, which is specific to dynamin-1, binds preferentially in BALB/cByJ cortex and induces substantial expression of cytokines mainly in the hypothalamus. Thus, an antibody to just one brain antigen can induce multiple behavioral changes, and multiple autoantibodies to different brain antigens exist in lupus-prone mice; however, susceptibility to the induction of neurobehavioral deficits is dependent on host genetics.
Introduction
As many as 70% of the individuals inflicted with SLE develop clinically noticeable psychiatric disorders, including cognitive impairment (Van Dam, 1991; Sibley et al., 1992; Hietaharju et al., 1993; Hay, 1994; West, 1994) . Due to the diverse array of aberrant manifestations (Hanly, 1998; Nadeau, 2002) , these nervous system disorders have been collectively referred to as neuropsychiatric SLE (NPSLE). It has been suggested that NPSLE is more common than glomerulonephritis (Sibbitt et al., 1992) . Some NPSLE symptoms have even been observed in children (Schor, 2000; Bankhurst and Brooks, 2002) . Although the proportion of patients with NPSLE is debatable (Ainiala et al., 2001; Monastero et al., 2001) , there is agreement that diagnosis and therapeutic intervention can be difficult and complex, owing to the variety of nervous system manifestations (Navarrete and Brey, 2000; Brey et al., 2002) . Assessment of NPSLE is dependent upon clinical evaluation, in addition to information from studies of autoantibodies (Bleiberg and Bunning, 1998), brain structure (Sibbitt et al., 1999) , and neural function (Sibbitt et al., 1997) .
The mechanisms associated with the variant NPSLE manifestations need to be differentially investigated, and a mouse model can be especially useful for this purpose. The NZB/NZW F1 mouse has long been the classical model with which to assess human SLE, in that the autoimmune disease pathologies of human and mouse lupus are very similar, including the facts that female mice are significantly more lupus-prone than are male mice and that nephritis is the major cause of mortality. Unfortunately, nephritis can lead to potential complications for the investigation of NPSLE, because renal pathology can affect nervous system functions,
